<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="2892">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on October 07, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04379544</url>
  </required_header>
  <id_info>
    <org_study_id>843008</org_study_id>
    <nct_id>NCT04379544</nct_id>
  </id_info>
  <brief_title>Prognostic Value of Point of Care Cardiac and Lung Ultrasound in COVID-19</brief_title>
  <acronym>CLUSCO</acronym>
  <official_title>Prognostic Value of Point of Care Cardiac and Lung Ultrasound in COVID-19</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Pennsylvania</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Pennsylvania</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a protocol-driven observational study of lung ultrasound and focused echocardiography
      images obtained in the Emergency Department (ED) and Intensive Care Unit (ICU) settings as a
      part of existing standard of care. The objectives of this study are as follows:

        1. To characterize various clinical and cardiopulmonary ultrasound findings and describe
           their relationship with the clinical course of patients with COVID-19 in the ED and ICU.

        2. To describe, develop, and validate a prediction tool that can accurately predict the
           need for invasive mechanical ventilation (IMV) and acute respiratory failure in COVID-19
           patients using clinical, laboratory, and ultrasound data.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Background and scientific rationale:

      During the COVID-19 pandemic, health care systems around the world are overwhelmed.

      Surge of patients requiring hospital admission have led to shortages of ICU beds and
      mechanical ventilators. As an emerging clinical entity, little is known about the precise
      pathophysiologic mechanisms of COVID-19. Recent observational data and clinical experience
      has suggested that there could be different phenotypes of patients with COVID-19 which could
      explain the wide range of clinical presentations, response to therapies and outcomes.

      Point of care cardiac and lung ultrasound (CLUS) has been proposed as a tool with potential
      to assist diagnostic evaluation and management of COVID-19 patients in the emergency
      department (ED) and intensive care unit (ICU) settings. Point of care CLUS is routinely used
      as part of the clinical evaluation of patients with dyspnea, hypoxemia, chest pain and shock
      in the ED and ICU. Patients with COVID-19 commonly present to the ED with these symptoms and
      therefore CLUS is being commonly used in patients with suspected or confirmed diagnosis of
      COVID-19.

      Small observational studies have described several lung ultrasound (LUS) findings in patients
      with COVID-19. These findings include; pleural irregularity (&quot;thickening&quot;), subpleural
      consolidations, air bronchogram, isolated B-lines, fused B-lines and pleural effusions. Other
      observational studies have described the presence of acute myocardial abnormalities in
      patients with COVID-19 seen in echocardiography, including left and right ventricular
      systolic dysfunction.

      Multiple studies have described and validated the finding of B-lines in LUS as a non-invasive
      marker of extravascular lung water. B-lines in LUS correlate with pulmonary capillary wedge
      pressures, NT-proBNP and E/e' and has been validated as a reliable prognostic factor in
      patients with decompensated heart failure. B-lines are also found in other pulmonary
      processes including viral pneumonia, ARDS, pulmonary contusions and post radiation changes.
      Observational studies involving COVID-19 patients have shown the presence of isolated and
      fused or continuous B-lines in the pneumonia associated with this infection. We hypothesize
      that the presence of B-lines in LUS may be marker of severity, and that alone or in concert
      with other clinical or laboratory variables, could help predict the clinical course and
      prognosis of COVID-19 patients.

      Knowledge gaps

        1. Does point of care cardiopulmonary ultrasound findings alone, or combined with other
           clinical and/or laboratory variables, predict clinical outcomes of patients with
           COVID-19?

        2. Can different lung ultrasound finding patterns correlate with clinical severity or
           outcomes?

      Specific aims

        1. To characterize various clinical and CLUS findings and describe their relationship with
           clinical course of patients with COVID-19 in ED and ICU.

        2. Using clinical, laboratory and ultrasound data to describe, develop and validate a
           prediction tool that can accurately predict (1) need of invasive mechanical ventilation
           (IVM) and (2) acute respiratory failure
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 23, 2020</start_date>
  <completion_date type="Anticipated">December 2020</completion_date>
  <primary_completion_date type="Anticipated">December 2020</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>1 Year</target_duration>
  <primary_outcome>
    <measure>Patient requires invasive mechanical ventilation and suffers from acute respiratory failure.</measure>
    <time_frame>1 Year</time_frame>
    <description>Number of patients requiring invasive mechanical ventilation and suffers from acute respiratory failure.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Patient is discharged</measure>
    <time_frame>1 Year</time_frame>
    <description>Number of patients that do not require hospitalization and is able to safely recover from COVID-19 at home.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Patient is hospitalized, but does not require mechanical ventilation through the duration of hospital stay.</measure>
    <time_frame>1 Year</time_frame>
    <description>Number of patients that must be hospitalized to recover from COVID-19, but does not require invasive mechanical ventilation and may or may not suffer from some degree of acute respiratory failure.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Lung ultrasound findings</measure>
    <time_frame>1 year</time_frame>
    <description>Any lung ultrasound findings including, but not limited to b-lines, a-lines, consolidations, pleural effusions and regularities. All of these findings are consolidated to a single score which will be the measure of the severity of lung ultrasound findings.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cardiac ultrasound findings</measure>
    <time_frame>1 year</time_frame>
    <description>Any cardiac ultrasound findings including, but not limited to IVC status, pericardial effusions, LV EF (%), RV function. All of these findings are consolidated to a single score which will be the measure of the severity of cardiac ultrasound findings.</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">105</enrollment>
  <condition>Coronavirus</condition>
  <condition>Respiratory Failure</condition>
  <arm_group>
    <arm_group_label>COVID-19 Positive Patients Receiving CPUS</arm_group_label>
    <description>Adult patients (18 years) presenting to the ED or ICU with highly suspected diagnosis or confirmed diagnosis of COVID-19 in whom the clinician deems a CPUS (cardiopulmonary ultrasound) is indicated.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Observation only</intervention_name>
    <description>There is no intervention. This study is purely observational. This study simply follows COVID-19 patients who get CPUS based on their clinician deeming it necessary.</description>
    <arm_group_label>COVID-19 Positive Patients Receiving CPUS</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Adult patients (&gt;18 years) patients presenting to the ED and ICU with suspected diagnosis
        or confirmed diagnosis of COVID-19 in whom the clinician deems a CLUS indicated.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  COVID-19 positive or suspected positive

          -  Received a cardiopulmonary ultrasound scan

        Exclusion Criteria:

          -  Did not receive a scan

          -  Not COVID-19 positive
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Felipe Teran, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Pennsylvania</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Felipe Teran, MD</last_name>
    <phone>2156623003</phone>
    <email>Felipe.Teran-Merino@pennmedicine.upenn.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Claire Centeno, EMT</last_name>
    <phone>3144012912</phone>
    <email>Claire.Centeno@pennmedicine.upenn.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University of Pennsylvania Health System</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19104</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Claire Centeno, EMT</last_name>
      <phone>314-401-2912</phone>
      <email>centenoc@sas.upenn.edu</email>
    </contact>
    <contact_backup>
      <last_name>Christy Moore</last_name>
      <phone>215-663-3920</phone>
      <email>Christy.Moore@pennmedicine.upenn.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Nova Panebianco, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Felipe Teran, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Cameron Baston, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Oscar Mitchell, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jeffery Kramer, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Deepti Kilaru, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Hari Shankar, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Nahreen Ahmed, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Steven Pugliese, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Meghan Lane-fall, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Dave Poliner, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jesse Kiefer, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Nathaniel Reisinger, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Scott Tilton</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Emily Gordon, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Scott Falk, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Brian Luu, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jennifer Morganroth, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>https://pennultrasound.org/clusco</url>
    <description>Study information site</description>
  </link>
  <reference>
    <citation>Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, Liu L, Shan H, Lei CL, Hui DSC, Du B, Li LJ, Zeng G, Yuen KY, Chen RC, Tang CL, Wang T, Chen PY, Xiang J, Li SY, Wang JL, Liang ZJ, Peng YX, Wei L, Liu Y, Hu YH, Peng P, Wang JM, Liu JY, Chen Z, Li G, Zheng ZJ, Qiu SQ, Luo J, Ye CJ, Zhu SY, Zhong NS; China Medical Treatment Expert Group for Covid-19. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med. 2020 Apr 30;382(18):1708-1720. doi: 10.1056/NEJMoa2002032. Epub 2020 Feb 28.</citation>
    <PMID>32109013</PMID>
  </reference>
  <reference>
    <citation>Grasselli G, Pesenti A, Cecconi M. Critical Care Utilization for the COVID-19 Outbreak in Lombardy, Italy: Early Experience and Forecast During an Emergency Response. JAMA. 2020 Apr 28;323(16):1545-1546. doi: 10.1001/jama.2020.4031.</citation>
    <PMID>32167538</PMID>
  </reference>
  <reference>
    <citation>Remuzzi A, Remuzzi G. COVID-19 and Italy: what next? Lancet. 2020 Apr 11;395(10231):1225-1228. doi: 10.1016/S0140-6736(20)30627-9. Epub 2020 Mar 13. Review.</citation>
    <PMID>32178769</PMID>
  </reference>
  <reference>
    <citation>Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, Wang B, Xiang H, Cheng Z, Xiong Y, Zhao Y, Li Y, Wang X, Peng Z. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA. 2020 Mar 17;323(11):1061-1069. doi: 10.1001/jama.2020.1585.</citation>
    <PMID>32031570</PMID>
  </reference>
  <reference>
    <citation>Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, Zhang L, Fan G, Xu J, Gu X, Cheng Z, Yu T, Xia J, Wei Y, Wu W, Xie X, Yin W, Li H, Liu M, Xiao Y, Gao H, Guo L, Xie J, Wang G, Jiang R, Gao Z, Jin Q, Wang J, Cao B. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020 Feb 15;395(10223):497-506. doi: 10.1016/S0140-6736(20)30183-5. Epub 2020 Jan 24. Erratum in: Lancet. 2020 Jan 30;:.</citation>
    <PMID>31986264</PMID>
  </reference>
  <reference>
    <citation>Yang X, Yu Y, Xu J, Shu H, Xia J, Liu H, Wu Y, Zhang L, Yu Z, Fang M, Yu T, Wang Y, Pan S, Zou X, Yuan S, Shang Y. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med. 2020 May;8(5):475-481. doi: 10.1016/S2213-2600(20)30079-5. Epub 2020 Feb 24. Erratum in: Lancet Respir Med. 2020 Apr;8(4):e26.</citation>
    <PMID>32105632</PMID>
  </reference>
  <reference>
    <citation>Arentz M, Yim E, Klaff L, Lokhandwala S, Riedo FX, Chong M, Lee M. Characteristics and Outcomes of 21 Critically Ill Patients With COVID-19 in Washington State. JAMA. 2020 Apr 28;323(16):1612-1614. doi: 10.1001/jama.2020.4326.</citation>
    <PMID>32191259</PMID>
  </reference>
  <reference>
    <citation>Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, Qiu Y, Wang J, Liu Y, Wei Y, Xia J, Yu T, Zhang X, Zhang L. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020 Feb 15;395(10223):507-513. doi: 10.1016/S0140-6736(20)30211-7. Epub 2020 Jan 30.</citation>
    <PMID>32007143</PMID>
  </reference>
  <reference>
    <citation>Spencer KT, Kimura BJ, Korcarz CE, Pellikka PA, Rahko PS, Siegel RJ. Focused cardiac ultrasound: recommendations from the American Society of Echocardiography. J Am Soc Echocardiogr. 2013 Jun;26(6):567-81. doi: 10.1016/j.echo.2013.04.001.</citation>
    <PMID>23711341</PMID>
  </reference>
  <reference>
    <citation>Long B, Brady WJ, Koyfman A, Gottlieb M. Cardiovascular complications in COVID-19. Am J Emerg Med. 2020 Jul;38(7):1504-1507. doi: 10.1016/j.ajem.2020.04.048. Epub 2020 Apr 18. Review.</citation>
    <PMID>32317203</PMID>
  </reference>
  <reference>
    <citation>Xie Y, Wang X, Yang P, Zhang S. COVID-19 Complicated by Acute Pulmonary Embolism. Radiol Cardiothorac Imaging. 2020 Apr 1;2(2):e200067</citation>
  </reference>
  <reference>
    <citation>Danzi GB, Loffi M, Galeazzi G, Gherbesi E. Acute pulmonary embolism and COVID-19 pneumonia: a random association? Eur Heart J. 2020 May 14;41(19):1858. doi: 10.1093/eurheartj/ehaa254.</citation>
    <PMID>32227120</PMID>
  </reference>
  <reference>
    <citation>Mitchell C, Collins K, Hua L, McClanahan C, Shea E, Umland M, Wasserman M. Specific Considerations for Sonographers When Performing Echocardiography during the 2019 Novel Coronavirus Outbreak: Supplement to the American Society of Echocardiography Statement. J Am Soc Echocardiogr. 2020 Jun;33(6):654-657. doi: 10.1016/j.echo.2020.04.014. Epub 2020 Apr 11. Review.</citation>
    <PMID>32503701</PMID>
  </reference>
  <reference>
    <citation>Hendren NS, Drazner MH, Bozkurt B, Cooper LT Jr. Description and Proposed Management of the Acute COVID-19 Cardiovascular Syndrome. Circulation. 2020 Jun 9;141(23):1903-1914. doi: 10.1161/CIRCULATIONAHA.120.047349. Epub 2020 Apr 16. Review.</citation>
    <PMID>32297796</PMID>
  </reference>
  <reference>
    <citation>Vieillard-Baron A, Price LC, Matthay MA. Acute cor pulmonale in ARDS. Intensive Care Med. 2013 Oct;39(10):1836-8. doi: 10.1007/s00134-013-3045-2. Epub 2013 Aug 2.</citation>
    <PMID>23907498</PMID>
  </reference>
  <verification_date>May 2020</verification_date>
  <study_first_submitted>May 4, 2020</study_first_submitted>
  <study_first_submitted_qc>May 6, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">May 7, 2020</study_first_posted>
  <last_update_submitted>May 8, 2020</last_update_submitted>
  <last_update_submitted_qc>May 8, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">May 11, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>COVID-19</keyword>
  <keyword>Ultrasound</keyword>
  <keyword>Point-of-care</keyword>
  <keyword>Lung Ultrasound</keyword>
  <keyword>Focused Echocardiography</keyword>
  <keyword>Emergency Department</keyword>
  <keyword>ICU</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Respiratory Insufficiency</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

